Glaxosmithkline PLC ORD 25P

GSK 
(LSE, Stocks) 
 

To view this page ensure that Adobe Flash Player version 10.0.0 or greater is installed.

p 1,636.87 <%= Resources.Global.txtDown %>
Updated 00:16:47
Change % -0.04% Stock price decreasing
Change -0.63 Stock price decreasing
Volume 0
High P 0
Low P 0
Open P 0
ISIN GB0009252882
Prev close P 1,637.50
# of shares -
Market cap -
Intraday

Market closed
Glaxosmithkline PLC ORD 25P
Market is closed, opens at 08:00
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  1,636.87 0.5% Stock price increasing -0.8% Stock price decreasing 8.1% Stock price increasing 17.8% Stock price increasing 30.9% Stock price increasing

Company profile

GlaxoSmithKline (GSK) is a global pharmaceutical company with the majority of sales coming from pharmaceuticals followed by consumer healthcare. Most of the growth for GSK is coming from consumer healthcare because of declining pharmaceutical sales and margins from mature markets. The sector is highly dependent on expensive, long term R&D to develop new drugs. To establish a stronger brand presence in China and India, the company has aggressively cut prices to increase volumes in these markets.

Copyright Euroinvestor A/S 2016   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
28 September 2016 02:43:28
(UTC) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20160921.1 - EUROWEB3 - 2016-09-28 03:43:28 - 2016-09-28 02:43:28 - 1000 - Website: OKAY